Rules and Regulations

Latest Issue of OR Manager
November 2025
Home Regulations/Legal > Rules and Regulations

Antitrust guideline withdrawal could dampen M&A, boost uncertainty for provider joint ventures

Editor's Note In a move that could hinder provider-led joint ventures and increase regulatory uncertainty, the Federal Trade Commission (FTC) and the Justice Department have withdrawn antitrust guidance issued in 2000. Modern Healthcare reported the news on December 16. Passed in a 3-2 vote, the decision eliminates previously relied-upon safe…

Read More

By: Matt Danford
December 18, 2024
Share

Infusion pump problems prompt early FDA safety warning

Editor's Note Risk of delayed therapy and death related to Ivenix large-volume infusion pumps is prompting supplier Fresenius Kabi USA to pull a subset of the devices from the market, according to an early alert from The US Food and Drug Administration (FDA). Issued December 11, the early alert is…

Read More

By: Matt Danford
December 12, 2024
Share

Analysis: Guidance from leading medical journals mixed on AI use

JAMA (healthcare publication) Network logo

Editor's Note Leading medical journals vary significantly in guidance addressing the use artificial intelligence (AI) in medical research, according to an analysis published December 3 in JAMA Network Open.   The study categorized journals’ attitudes toward AI-assisted peer review into three groups: prohibition, limited use with conditions, and lack of explicit…

Read More

By: Matt Danford
December 10, 2024
Share

Advanced practice providers fill capacity gaps amid continued scope-of-practice debates

Editor's Note A recent report in Becker’s Hospital Review illuminated health systems’ efforts to address physician shortage by integrating advanced practice providers (APPs) into care models. Citing projections from the Bureau of Labor Statistics (BLS), Becker’s noted that nurse practitioners (NPs) “are the fastest-growing occupation in the country, with employment in…

Read More

By: Matt Danford
December 6, 2024
Share

Sponsored Message

FDA designates Class 1 recall for insulin syringes

Editor's Note The US Food and Drug Administration (FDA) designated Cardinal health’s recall of certain lots of the Monoject U-100 1 mL Syringe Luer-Lock with Tip Cap Soft Pack a Class 1, the most severe recall category indicating serious risk of injury or death. The product is designed to administer…

Read More

By: Matt Danford
December 5, 2024
Share

Study: Masking policies significantly reduce hospital-acquired viral respiratory infections

JAMA (healthcare publication) Network logo

Editor's Note A cohort study conducted across 10 hospitals in the Mass General Brigham system found that stopping universal masking and SARS-CoV-2 testing significantly increased hospital-onset respiratory viral infections, while reinstating masking for healthcare workers reduced those rates. As detailed in a November 27 research letter in Jama Network Open,…

Read More

By: Matt Danford
December 5, 2024
Share

Sponsored Message

HHS finalizes rule to expand kidney transplant access

Centers for Medicare & Medicaid Services

Editor's Note The US Department of Health and Human Services (HHS) finalized a new rule establishing the Increasing Organ Transplant Access Model, a 6-year, mandatory initiative to enhance access to kidney transplants, improve care quality, and reduce disparities. Managed by the Centers for Medicare & Medicaid Services (CMS), the program…

Read More

By: Matt Danford
December 4, 2024
Share

FDA pilot program aims to expedite high-risk medical device recall communication

Editor's Note The US Food and Drug Administration’s (FDA’s) Center for Devices and Radiological Health (CDRH) has initiated a pilot program to improve the speed of public notifications regarding high-risk medical device recalls. According to a November 21 announcement, this initiative aims to minimize the time between the FDA's awareness…

Read More

By: Matt Danford
December 2, 2024
Share

FDA Class 1 recalls target anesthesia workstations, ambulatory infusion pumps, ventilators

Editor's Note The US Food and Drug Administration (FDA) has designated Class 1 recalls—the most severe category indicating risk of serious injury or death—involving three systems: Atlan anesthesia workstations from Draeger, CADD-Solis ambulatory infusion pumps from Smiths Medical, and Trilogy Evo ventilators from Philips Respironics. FDA issued all three announcements…

Read More

By: Matt Danford
November 20, 2024
Share

Practice updates ease steam sterilization balancing act

Reliable and robust enough for daily use on most medical devices, steam is the most common sterilant in healthcare facilities. However, using steam properly requires a balancing act. For example, too much moisture can lead to wet packs, while steam that is too dry might not be sufficient to achieve…

Read More

By: Susan Klacik, BS, FCS, ACE, CHL, CIS, CRCST, AAMIF
November 20, 2024
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat